The nation of Zimbabwe has turned down a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of Washington's request for sensitive data.
This move became public following a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "unbalanced".
An official spokesman has since stated that the United States was seeking health data for scientific study and commercial gain but refused to guarantee the benefits from future vaccines.
"We must now begin the challenging and unfortunate process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for continued negotiations to reach a deal acceptable to all parties so the nation's vital HIV treatment initiative can be sustained.
Broader Implications
This rejection comes after a similar situation in neighbouring Kenya, where a court halted a similar deal with the US following concerns were raised about the security of Kenyans' health data.
Since resuming office recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump stated its spending was "inefficient" and his government was seeking government-to-government agreements to enhance openness and responsibility.
Based on statements, Sixteen nations in Africa have to date signed similar health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to provide its genetic material and health information indefinitely, without any corresponding guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"Effectively, our nation would provide the raw materials for medical research without any certainty that the end products would be available to our people should a future disease outbreak arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting frameworks already established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system created to deal with future pandemics.
"This mechanism is designed to guarantee that when a country contributes its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
The government's concerns regarding the US deal "are not meant as opposition to America," he added.
"We welcome continued discussions with our US partners on how future collaboration could be arranged in a manner that honours the independence and dignity of both nations."
Medical Community Reaction
Medical experts expressed it understood the government's concerns, but recommended that negotiations need to persist since much of the nation's Aids initiatives relied on international support.
"If technical issues exist, including those relating to data governance or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," it commented.
This impasse highlights the ongoing debate between receiving crucial foreign assistance and protecting local interests in an increasingly interconnected world.